Therapeutic efficacy of latanoprost on primary open angle glaucoma: A protocol for a systematic review of randomized controlled trial

BACKGROUND: Latanoprost is quiet new formulation that is approved for the treatment of primary open angle glaucoma (POAG). However, no updated systematic review has addressed its efficacy for POAG. This systematic review of randomized controlled trials (RCTs) aims to assess its efficacy and safety f...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Hai-yan, Wang, Jia-ying, Li, Yan-qing, Diao, Hui-jie, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320140/
https://www.ncbi.nlm.nih.gov/pubmed/30572551
http://dx.doi.org/10.1097/MD.0000000000013833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320140/
https://www.ncbi.nlm.nih.gov/pubmed/30572551
http://dx.doi.org/10.1097/MD.0000000000013833

Ejemplares similares